https://www.selleckchem.com/
Preclinical and clinical findings suggest sexual dimorphism in cardiotoxicity induced by a chemotherapeutic drug, doxorubicin (DOX). However, molecular alterations leading to sex-related differential vulnerability of heart to DOX toxicity are not fully explored. In the present study, RNA sequencing in hearts of B6C3F1 mice indicated more differentially expressed genes in males than females (224 vs. 19; ≥1.5-fold, False Discovery Rate [FDR] less then 0.05) at 1 week after receiving 24 mg/kg total cumulative DOX dose that induced cardiac lesions only in mal
Aimer
Commentaire
Partagez
